Price To Earnings Ratio 105.37 | Sector PE 69.47 |
PB Ratio 18.55 | Sector PB 9.32 |
EPS 26.91 | Dividend Yield 0.19 |
Today's Volume 549.609 K | 5 Day Avg. Volume 201.832 K |
PEG Ratio 2.39 | Market Cap. ₹ 28,190.00 Cr. |
Time | POLYMED | VS | Industry |
---|---|---|---|
1 Day | 2.93% | 2.93% | |
1 Week | 7.02% | 7.02% | |
1 Month | -9.32% | -9.32% | |
6 Months | 45.8% | 45.8% | |
1 Year | 78.52% | 78.52% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 2715.85 | Bullish |
20 | 2698.6 | Bullish |
30 | 2687.71 | Bullish |
50 | 2544.2 | Bullish |
100 | 2383.53 | Bullish |
200 | 2101.19 | Bullish |
Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |||||
---|---|---|---|---|---|---|---|---|---|
Operating Activities | 266.08 | 191.05 | 123.47 | 118.73 | |||||
Investing Activities | -240.94 | -179.24 | -85.33 | -435.58 | |||||
Financing Activities | -20.15 | -12.51 | -35.34 | 316.95 | |||||
Net Cash Flow | 4.99 | -0.69 | 2.80 | 0.10 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
Poly Medicure | 2.93 | 7.02 | -9.32 | 45.8 | 78.52 |
Alembic | 1.66 | 6.55 | 4.98 | 2.76 | 2.76 |
Aurobindo Pharma | 0.39 | 3.15 | -9.87 | -7.14 | 16.99 |
Fortis Healthcare | 2.25 | 10.82 | 13.14 | 42.21 | 81.43 |
Ajanta Pharmaceuticals | 0.27 | -1.65 | -3.39 | 19 | 46.25 |
Poly Medicure Limited is an Indian medical device manufacturing company. The company's field of activity is the production and sale of medical equipment. The company offers a diverse range of medical devices in the product areas of infusion therapy, oncology, anaesthesia and respiratory therapy, covid therapy, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It delivers its products to around 120 countries in Europe, Africa, America, Australia and Asia. Its products include suction control valve, safety arterial cannula, VTM series, VLTM series, rebound blood collection needle and prefilled syringes. The company has nine manufacturing facilities in India, China, Egypt and Italy. It has six manufacturing facilities in India, four of which are located in Faridabad (Haryana) and one each in Jaipur (Rajasthan) and Haridwar (Uttarakhand).